# Sangamo Therapeutics, Inc: Form 8-K, filed Apr 30, 2024

- Company: [Sangamo Therapeutics, Inc](/companies/sgmoq.md) (CIK 1001233)
- Form: 8-K
- Filed: 2024-04-30
- Accepted by EDGAR: Apr 30, 2024, 16:02 ET
- Period: 2024-04-24
- Accession: 0001628280-24-019337
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1001233/000162828024019337/sgmo-20240424.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1001233/000162828024019337/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1001233/000162828024019337/sgmo-20240424.htm

Filed Apr 30, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-019337. Last ingested by Listed: Oct 27, 2026, 16:02 ET. No prices; not investment advice.